Browse by author
Lookup NU author(s): John Williams
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
To assist surgeons select a suitable prosthesis, we have undertaken a detailed review of all shoulder and elbow replacements currently marketed in the UK. Twenty shoulder and 8 elbow implants, manufactured by 16 companies, have been identified. Twelve of the shoulder and one of the elbow implants have been introduced or modified in the last 8 years and have no clinical results published in peer-reviewed journals. Only the Biomodular, Bipolar, Copeland, Isoelastic, Neer hemi, Neer II, Roper-Day and Select shoulders accounting for less than 40% of the UK shoulder market, possess published results. The Capitello-condylar, Coonrad-Morrey, GSB III, Kudo, Liverpool, Roper-Tuke and Souter-Strathclyde elbows all have published results. These account for over 95% of all UK elbow replacements. The implications of these findings in an era of evidence-based medicine is discussed. Reviewing the clinical results should be of primary importance in the selection of a suitable prosthesis. Implants with a proven long-term record must represent the 'gold standard'. New or modified implants should only be used if they are part of a properly conducted clinical trial.
Author(s): Mackay DC, Hudson B, Williams JR
Publication type: Article
Publication status: Published
Journal: Annals of the Royal College of Surgeons of England
Year: 2001
Volume: 83
Issue: 4
Pages: 258-265
ISSN (print): 0035-8843
ISSN (electronic): 1478-7083
Publisher: The Royal College of Surgeons of England
